St Cross Alumnus Boon Lim Recognised in Forbes 30 Under 30 List

Boon Lim (DPhil Synthetic Biology, 2017) has been selected as one of Forbes 30 Under 30 Europe 2023 in the Science and Healthcare category. 

Lim, who is Chief Technology Officer at the University of Oxford spin-out SimCell, has been recognised for work that focuses on tackling the growing challenge of antimicrobial resistance (AMR).

It is a great honour, and I'm truly humbled to be selected. This recognition is a testament to the hard work and dedication I have put in to make a positive impact in the world.

This award is a significant milestone; however, I hope that it will not be the biggest highlight of my career, but instead a stepping stone towards a more exciting future.

Lim had occasionally heard of AMR throughout his education, but it wasn’t until his PhD studies at the University of Oxford as a St Cross College student that he became engrossed in the field.

During his time at the College, Lim was a recipient of a St Cross Community Bursary – an award, provided by the generous support of David Scrymgeour, for students based on their demonstrated achievements and commitment to supporting their own personal development, leadership skills, and entrepreneurial spirit.

Lim also received the Ralph A. Lewin Prize, which is an award honouring a pioneer of Marine Biology and is available to available to Biological, Environmental or Medical Sciences students.

As well as appreciating the funding support that he received during his time at the College, Lim also fondly remembers the delicious food and the friendly staff, and he cherished the “diverse, vibrant and international” community. 

Lim is now focused on making a positive impact via research and development, aiming to apply his expertise and skills to develop impactful vaccine products.